MedPath

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Not Applicable
Recruiting
Conditions
Laryngectomy; Status
Interventions
Device: Provox Life
Registration Number
NCT06084611
Lead Sponsor
Atos Medical AB
Brief Summary

Assessment of long term effect of Provox Life HME use on pulmonary symptoms in laryngectomized patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Total laryngectomy, irrespective of pharynx reconstruction method
  • 18 years or older
  • Longer than 3 months after total laryngectomy
  • Longer than 6 weeks after postoperative radiotherapy
Exclusion Criteria
  • Current use of HMEs (within last 3 months)
  • Medical problems prohibiting the use of HME
  • Active recurrent or metastatic disease (medical deterioration)
  • Recent pulmonary infections/unstable pulmonary condition
  • Insufficient physical, cognitive, or mental ability required to attach, remove or operate the devices themselves
  • Low tidal volumes
  • Unable to understand the Participant Information and/or unable to give Informed Consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Provox Life HMEProvox LifeUse of Provox Life HMEs and attachment
Primary Outcome Measures
NameTimeMethod
CASA-Q ScoreBaseline, 3 months, 6 months, 9 months

assessed with validated Coughing and Sputum Assessment Questionnaire (CASA-Q). Score between 0 and 100, with higher scores meaning less symptoms and less impact.

Secondary Outcome Measures
NameTimeMethod
Quality of Life by EQ-5D-5LBaseline, 3 months, 6 months, 9 months

patient reported, the descriptive system assesses health in five dimensions, from which a health state index score is calculated, range from 0 to 1, with higher scores indicating higher health utility

Jenkins sleep evaluation questionnaireBaseline, 3 months, 6 months, 9 months

Patient reported to assess sleep quality. Score between 0 and 20, with higher score the more sleep disturbances

Number of involuntary coughs per 24 hoursBaseline, 3 months, 6 months, 9 months

Patient reported, recorded by tally sheeting

Forced ExpectorationBaseline, 3 months, 6 months, 9 months

Patient reported, recorded by tally sheeting

Study-specific questionnaire to assess number of complications and medical treatmentsBaseline, 3 months, 6 months, 9 months

Study specific questionnaire to record complications and consumption of medications, diagnostics, treatment, medical care, medical transportation, sick leave

Questionnaire to assess Shortness of BreathBaseline, 3 months, 6 months, 9 months

from Ackerstaff et al., 1993

Voice handicap IndexBaseline, 3 months, 6 months, 9 months

patient reported outcome, score from 0-40, with higher scores indicating greater voice-related handicap.

Consumption of medical devices (Number of devices used)Baseline, 3 months, 6 months, 9 months

Number of devices used, by use of patient diary recoding number of devices used

Trial Locations

Locations (1)

Instituto de Cancer Dr. Arnaldo

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath